# Preservation of Ovarian Function After Hematopoietic Cell Transplant

> **NCT01343368** · PHASE2 · TERMINATED · sponsor: **Masonic Cancer Center, University of Minnesota** · enrollment: 19 (actual)

## Conditions studied

- Multiple Myeloma
- Non-Hodgkin Lymphoma
- Hodgkin Disease
- Acute Myeloid Leukemia
- Myeloproliferative Disorders

## Interventions

- **DRUG:** Leuprolide
- **BIOLOGICAL:** hematopoietic cell transplant
- **BIOLOGICAL:** reduced intensity allogeneic HCT

## Key facts

- **NCT ID:** NCT01343368
- **Lead sponsor:** Masonic Cancer Center, University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 19 (ACTUAL)
- **Last updated:** 2017-12-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01343368

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01343368, "Preservation of Ovarian Function After Hematopoietic Cell Transplant". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01343368. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*